Extract from M&A Insights

The below story was originally featured in our daily M&A Insights Newsletter. Selected stories, including this one, are posted to our website with a few weeks of delay.
Abacus Medicine postpones IPO two days before initial trading
May 31, 2019

Abacus Medicine, a Danish-based pharmaceutical provider, that last week published its intention to go public has postponed the IPO due to unfavourable market conditions. The same happened in fall 2018 where Abacus also postponed its IPO.

ⓘ This story was originally featured in our daily M&A Insights newsletter.
Our insights have been covered by: